UL Solutions Inc. (ULS)
USD 49.85
(-2.14%)
USD 49.85
(-2.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2.67 Billion | 2.52 Billion | 2.51 Billion | 2.3 Billion | 2.31 Billion |
| Cost of Revenue | 1.41 Billion | 1.31 Billion | 1.33 Billion | 1.27 Billion | 1.28 Billion |
| Gross Profit | 1.26 Billion | 1.2 Billion | 1.17 Billion | 1.03 Billion | 1.03 Billion |
| Operating Expenses | 860 Million | 795 Million | 892 Million | 668 Million | 715 Million |
| Selling, General and Administrative Expenses | 860 Million | 795 Million | 892 Million | 668 Million | 723 Million |
| Research and Development Expenses | 51 Million | 43 Million | 45 Million | - | 52 Million |
| Other Expenses | - | 5 Million | 2 Million | - | - |
| Cost and Expenses | 2.31 Billion | 2.1 Billion | 2.23 Billion | 1.93 Billion | 1.99 Billion |
| Operating Income | 368 Million | 412 Million | 287 Million | 363 Million | 312 Million |
| Interest Expense | 35 Million | 17 Million | 1 Million | 1 Million | - |
| Income Tax Expense | 70 Million | 74 Million | 36 Million | 90 Million | 62 Million |
| Earnings before Tax | 346 Million | 383 Million | 274 Million | 333 Million | 319 Million |
| Net Income | 260 Million | 293 Million | 224 Million | 231 Million | 246 Million |
| Earnings Per Share Basic | 1.30 | 1.47 | 1.12 | 1.16 | 1.23 |
| Earnings Per Share Diluted | 1.30 | 1.47 | 1.12 | 1.16 | 1.23 |
| Weighted Average Shares Outstanding | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million |
| Weighted Average Shares Outstanding (Diluted) | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million |
| Gross Margin | 0.47 | 0.48 | 0.47 | 0.45 | 0.45 |
| EBIT Margin | 0.20 | 0.22 | 0.17 | 0.22 | 0.18 |
| Profit Margin | 0.10 | 0.12 | 0.09 | 0.10 | 0.11 |
| EBITDA | 535 Million | 535 Million | 417 Million | 481 Million | 408 Million |
| Earnings Before Tax Margin | 0.14 | 0.16 | 0.11 | 0.16 | 0.13 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 731 Million | 730 Million | 670 Million | 2.67 Billion | 684 Million | 676 Million |
| Cost of Revenue | 373 Million | 364 Million | 351 Million | 1.41 Billion | 367 Million | 344 Million |
| Gross Profit | 358 Million | 366 Million | 319 Million | 1.26 Billion | 317 Million | 332 Million |
| Operating Expenses | 228 Million | 240 Million | 228 Million | 860 Million | 230 Million | 205 Million |
| Selling, General and Administrative Expenses | 228 Million | 240 Million | 228 Million | - | 230 Million | 205 Million |
| Research and Development Expenses | - | - | - | - | 51 Million | - |
| Other Expenses | - | 1 Million | 2 Million | 3 Million | -4 Million | -2 Million |
| Cost and Expenses | 601 Million | 604 Million | 579 Million | 2.27 Billion | 597 Million | 549 Million |
| Operating Income | 130 Million | 126 Million | 91 Million | 405 Million | 87 Million | 127 Million |
| Interest Expense | -14 Million | 13 Million | 15 Million | 35 Million | 12 Million | 7 Million |
| Income Tax Expense | 22 Million | 28 Million | 13 Million | 70 Million | 17 Million | 18 Million |
| Earnings before Tax | 116 Million | 134 Million | 73 Million | 346 Million | 79 Million | 75 Million |
| Net Income | 88 Million | 101 Million | 56 Million | 260 Million | 58 Million | 53 Million |
| Earnings Per Share Basic | 0.44 | 0.51 | 0.28 | - | 0.29 | 0.27 |
| Earnings Per Share Diluted | 0.44 | 0.51 | 0.28 | - | 0.29 | 0.27 |
| Weighted Average Shares Outstanding | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million |
| Weighted Average Shares Outstanding (Diluted) | 202 Million | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million |
| Gross Margin | 0.49 | 0.50 | 0.48 | 0.47 | 0.46 | 0.49 |
| EBIT Margin | 0.18 | 0.23 | 0.20 | - | 0.19 | 0.24 |
| Profit Margin | 0.12 | 0.14 | 0.08 | 0.10 | 0.08 | 0.08 |
| EBITDA | 130 Million | 167 Million | 132 Million | - | 130 Million | 164 Million |
| Earnings Before Tax Margin | 0.18 | 0.17 | 0.14 | 0.15 | 0.13 | 0.19 |
CAM
544
0405
RCAT
OCA
RCKTF